510(k) K061249
K061249 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "AXSYM DIGOXIN III". The FDA issued a decision of Substantially Equivalent on June 2, 2006. The device falls under product code KXT (Enzyme Immunoassay, Digoxin), a Class II device regulated under 21 CFR 862.3320. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- June 2, 2006
- Date Received
- May 4, 2006
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Enzyme Immunoassay, Digoxin
- Device Class
- Class II
- Regulation Number
- 862.3320
- Review Panel
- TX
- Submission Type